Author Archive for: mantezzo
About Mia Antezzo
Mia Antezzo joined NASHP in September 2020 as a research analyst with the Behavioral Health, Aging, and Disability team. She is involved with projects related to substance use disorder, behavioral health, and palliative care. Prior to joining NASHP, she worked as a paralegal and legal writer in criminal defense and immigration firms in Los Angeles. Mia graduated from Oberlin College in 2018 with a BA in political science, with an emphasis on urban studies.
Entries by Mia Antezzo
Investments in Behavioral Health Service Systems: Top Three Emerging Themes from State Home and Community-Based Services Spending Plans
October 18, 2021 in Behavioral/Mental Health and SUD Blogs, Featured News Home Behavioral/Mental Health and SUD, Relief and Recovery /by Mia AntezzoStates, taking advantage of federal flexibilities and new federal funding, are implementing policy changes that seek to increase availability of and equitable access to behavioral health services. In anticipation of the one-year, 10% increase in the federal medical assistance percentages (FMAP), provided by the American Rescue Plan Act (ARPA), states have submitted spending plans to […]
State Approaches to Leveraging Neonatal Abstinence Syndrome Data to Inform Policymaking
August 16, 2021 in Opioid Center Kentucky, Ohio, Pennsylvania, Tennessee Featured News Home, Reports Behavioral/Mental Health and SUD, Opioid Use Disorder /by Eliza Mette, Jodi Manz, Kitty Purington and Mia AntezzoMassachusetts Uses Opioid Legal Settlement to Advance Equity in Access to Medications for Opioid Use Disorder
June 7, 2021 in Opioid Center Massachusetts Blogs, Featured News Home Behavioral/Mental Health and SUD, Opioid Use Disorder /by Mia Antezzo and Jodi ManzNationwide, overdose fatalities continue to climb, and racial disparities in overdose rates persist. Black Americans have experienced the steepest increase in opioid-related overdoses among all groups in recent years, despite the rate of opioid use remaining higher among Whites. While the past few years have seen a significant uptick in the use of buprenorphine to […]
Applications open for #NASHPCONF21 Workgroup: Expanding and Sustaining the Continuum of Care for People with Serious Illness
May 7, 2021 in Palliative Care Featured News Home Palliative Care /by Mia AntezzoThe National Academy for State Health Policy (NASHP), with generous support from The John A. Hartford Foundation, will be convening a state-only preconference workgroup at its #NASHPCONF21 annual state health policy conference, scheduled for September 20th, 2021 1-4pm EST, to explore expanding and sustaining the continuum of care for people with serious illness within Medicaid managed care systems. The workgroup will engage state leaders from 10 […]
Maryland’s Family Recovery Courts: Successfully Reuniting Families with the Help of Customized Substance Use Disorder Treatment
March 22, 2021 in Policy Maryland Blogs, Featured News Home Behavioral/Mental Health and SUD, Care Coordination, Chronic and Complex Populations, Integrated for Pregnant/Parenting Women, Maternal Health and Mortality, Maternal, Child, and Adolescent Health /by Mia AntezzoTo reduce substance use as a key cause of children removed from their homes, Maryland implemented a Family Recovery Court program in 2004 that connects parents to intensive treatment for substance use disorder (SUD) and provides case management and incentives. Over a one-year period, program evaluations show the program produced a 25 percent higher reunification […]
Q&A: How Louisiana Has Retooled its Harm Reduction Services for Vulnerable Populations during COVID-19
November 23, 2020 in Policy Louisiana Blogs, Featured News Home Behavioral/Mental Health and SUD, Chronic and Complex Populations, Chronic Disease Prevention and Management, COVID-19, Health Coverage and Access, Health Equity, HIV/AIDS, Physical and Behavioral Health Integration, Population Health, Safety Net Providers and Rural Health, Social Determinants of Health /by Eliza Mette, Mia Antezzo and Jodi ManzAs drug overdose deaths accelerate during the COVID-19 pandemic, states are working to ensure that a continuum of services, including access to harm reduction programs, remain available to people with substance use disorder (SUD). The National Academy for State Health Policy (NASHP) recently spoke to Louisiana’s Viral Hepatitis Coordinator Emilia Myers and STD/HIV/Hepatitis Program Deputy […]
Harm Reduction in the COVID-19 Era: States Respond with Innovations
October 19, 2020 in COVID-19 State Action Center Blogs, Featured News Home Behavioral/Mental Health and SUD, Chronic and Complex Populations, Chronic Disease Prevention and Management, COVID-19, Health Equity, Population Health /by Mia Antezzo, Eliza Mette and Jodi ManzDespite COVID-19 workarounds, such as telehealth and virtual recovery programs enabled by flexible federal guidelines, more than 40 states have reported increases in drug overdoses during the pandemic, underscoring the importance of keeping state harm reduction programs as accessible as possible. As COVID-19 upends the nation’s health care systems, treatment for substance use disorder (SUD) […]
Sign Up for Our Weekly Newsletter
Sign Up for Our Weekly Newsletter
Washington, DC Office:
1233 20th St., N.W., Suite 303Washington, DC 20036
p: (202) 903-0101
f: (202) 903-2790
Contact Us
Phone: 202-903-0101

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































